AKRX up +2.53% percent Today $AKRX High is at 38.91 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
AKRX up +2.53% percent Today $AKRX High is at 38.91 and the Low 37.72 with current volume of 155,850.

Recent News posted below.

Akorn Inc AKRX other info.
http://investorshangout.com/Akorn-AKRX-53272/

AKRX Akorn Inc Recent Headline News

Earnings Look Back: Akorn Is Up 0.9% Since Reporting Quarterly Results 1 Week Ago (AKRX)
Comtex SmarTrend(R) - Mon Nov 17, 4:05PM CST
When Akorn (NASDAQ:AKRX) reported earnings 11 days ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.25 on sales of $155.3 million. The company actually reported EPS of $0.27 on sales of $132.7 million, beating EPS estimates by $0.02 and missing revenue estimates by $22.5 million. Since the company's report, shares of Akorn have risen from $37.88 to $38.21, representing a gain of 0.9% in the past 11 days.
AKRX: 38.27 (+0.38)

AxoGen (AXGN) Looks Good: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:46AM CST
AxoGen (AXGN) was a big mover last session, with shares rising nearly 6% on the day.
IPXL: 29.48 (+0.77), AXGN: 2.70 (+0.06), AKRX: 38.27 (+0.38), MYL: 56.10 (+0.97)

Medical Stocks Tumble But Most Of IBD 50 Trading Well
at Investor's Business Daily - Fri Nov 14, 5:47PM CST
A few medical leading stocks have slid, but otherwise the IBD 50 remained in good shape last week. Illumina (ILMN) and Akorn (AKRX) have fallen below their buy points, while Alexion Pharmaceuticals (ALXN) and Celgene (CELG) exhibited some weakness of...
AKRX: 38.27 (+0.38), ALXN: 192.34 (+5.56), FFIV: 128.18 (+0.32), ILMN: 191.41 (+8.50), SPR: 41.92 (+0.85), AAPL: 115.45 (+1.46), ATHM: 41.82 (-1.03), BITA: 93.78 (+4.40), CELG: 106.94 (+2.58)

SmarTrend Watching for Potential Pullback in Shares of Akorn After 1.41% Gain
Comtex SmarTrend(R) - Fri Nov 14, 4:54PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.90 to a high of $38.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $37.85 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 38.27 (+0.38)

Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:40PM CST
Synageva BioPharma Corp. (GEVA) announced the presentation of new data from a phase III study on sebelipase alfa for LAL deficiency.
GEVA: 76.20 (-0.86), AKRX: 38.27 (+0.38), ADHD: 3.24 (-0.21), CELG: 106.94 (+2.58)

Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 89.33 (+0.90), KBIO: 1.99 (unch), AKRX: 38.27 (+0.38), MYL: 56.10 (+0.97)

Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Fri Nov 14, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $37.68 on volume of 3.0 million shares, above average daily volume of 1.7 million. Akorn (NASDAQ:AKRX) has potential upside of 9.0% based on a current price of $37.68 and analysts' consensus price target of $41.08. Akorn shares should encounter resistance at the 50-day moving average (MA) of $38.00 and support at its 200-day MA of $30.77.
AKRX: 38.27 (+0.38)

Stocks Rally Back After Midday Sell-Off
at Investor's Business Daily - Thu Nov 13, 12:17PM CST
Stocks were trying to recover after a midday sell-off lopped off most of the morning gains. The Nasdaq rose 0.3%, the S&P 500 was flat and the Dow Jones industrial average was up 0.2%. Volume was running at a higher pace than at the same time...
DDS: 109.22 (-0.60), AKRX: 38.27 (+0.38), WMT: 83.78 (+0.21), THRM: 40.64 (+0.86)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 86.02 (+0.32), AKRX: 38.27 (+0.38), WPC: 66.56 (+0.51), FLWS: 8.61 (-0.03), MMSI: 14.87 (+0.01)

Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 52.70 (+3.92), AKRX: 38.27 (+0.38), AEO: 13.26 (-0.08), M: 61.38 (-0.23), FANG: 64.30 (+0.58)

Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.27 (+0.38)

Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 38.27 (+0.38)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.35 (+0.35), LCI: 47.26 (+0.62), AKRX: 38.27 (+0.38), AFSI: 52.90 (+0.29), EXPE: 87.92 (+0.98), FFIV: 128.18 (+0.32), SLXP: 104.05 (+2.84), MPWR: 46.41 (+1.43), TMH: 55.06 (+0.23), ATHM: 41.82 (-1.03)

Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 108.77 (-1.30), ANET: 76.83 (+0.13), AKRX: 38.27 (+0.38), ATHM: 41.82 (-1.03)

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 36.35 (+0.35), HD: 96.62 (-1.41), AKRX: 38.27 (+0.38), ILMN: 191.41 (+8.50)

SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.27 (+0.38)

Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 85.18 (+3.68), SWIR: 39.92 (+1.27), AAP: 146.09 (+0.26), AKRX: 38.27 (+0.38), BABA: 111.66 (-2.59)

Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST

AKRX: 38.27 (+0.38)

Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 38.27 (+0.38)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 101

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 103

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 76

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 62

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading

Top 5 Most Recently Viewed Articles

Redsun Properties Faces $350 Million Bond Payment Crisis Ahead

Updated Category News Views 189

Redsun Properties Announces Inability to Pay Bond Chinese property developer Redsun Properties has communicated its inability to meet a $350 million bond payment, which is due shortly. This situation has raised considerable concern within the financial markets as it highlights the ongoing issues facing property developers in China. Details of the Bond Issue This bond,...

Continue Reading
Etruscus Resources Unveils Promising Findings at Zappa Target

Updated Category News Views 135

Etruscus Resources Makes Progress at Key Exploration Sites Etruscus Resources Corp. is thrilled to report on the encouraging findings from its exploration program at the Rock & Roll Property. This property is situated in the Golden Triangle region, known for its wealth of mineral resources. The exploration program, which included comprehensive rock sampling and geological...

Continue Reading
MetLife's Strategic Focus: Navigating Q3 2024 Earnings

Updated Category News Views 1091

MetLife Announces Q3 2024 Results and New Frontier Strategy In the third quarter of 2024, MetLife, Inc. (MET) reported adjusted earnings of $1.4 billion, translating to $1.93 per share. This reflects a decline from previous year figures, yet a 12% year-to-date increase in adjusted earnings per share (EPS) excluding notable items. The insurance powerhouse has seen positive...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 125

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading
Expanding Diabetes Care: From Monitoring to Change

Updated Category News Views 44

Breaking Ground at the AGP & DTx Summit Diabetes management ain't what it used to be, and the 4th AGP & DTx Summit in Shenzhen gave us an eyeful of change. Under the banner "Beyond Glucose," experts from all corners came together to talk shop about Continuous Glucose Monitoring (CGM) and how it might shake up diabetes care. CGM: More Than a Gadget See, CGM's not just a...

Continue Reading